Product Images Doxazosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Doxazosin NDC 42254-075 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Study 2 Maximum Flow Rate - 426f6918 7705 4988 a875 823196f43859 02
This text appears to describe the results of "Study 2" that looked at the maximum flow rate and symptom score for a placebo and two doses (4mg and 8mg) of a medication. However, the meaning and context of these numbers cannot be fully determined without additional information on the study and medication.*
Figure 1 - Study 1 - 426f6918 7705 4988 a875 823196f43859 03
The text appears to be a table describing the mean increase in maximum urinary flow rate and mean change in total symptom score from baseline for a duration of treatment in weeks for a placebo and a drug called Doxazosin. The table includes numerical values for each category and specifies the significance levels for the data compared to placebo and baseline. The drug was titrated up to a maximum of 8 mg.*
Doxazosin 2mg - 426f6918 7705 4988 a875 823196f43859 04
This is a description of a medication called Doxazosin 2mg. It is packaged in a bottle with 30 tablets, and the product ID is QD007530CA. The medication is manufactured by Novopharm Limited in Toronto, Canada. The pills are white and capsule-shaped. The package should be stored at a controlled room temperature between 15°C-30°C. The medication is only available through a prescription from a physician.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.